Therefore, the potential application of IL-17E in treating kidney diseases, particularly in mitigating kidney injury caused by IRI, drug toxicity, or obesity, warrants further clinical research and exploration (Fig. 3E and Fig. S7). The gene discussed is IL25; the disease is Obesity.